Registered number
15013569
DYSMA HEALTH CARE LIMITED
Report and Accounts
31 July 2024
DYSMA HEALTH CARE LIMITED
Report and accounts
Contents
Page
Company information 1
Director's report 2
Accountants' report 3
Profit and loss account 4
Balance sheet 5
Statement of changes in equity 6
Notes to the accounts 7-8
DYSMA HEALTH CARE LIMITED
Company Information
Director
Gladys Musu Prescod
Accountants
Hamlet Accountants Ltd
266 - 268 Bethnal Green Road
London
E2 0AG
Bankers
TSB
Registered office
Flat 109 Bentworth Court
80 Granby Street
London
E2 6DN
Registered number
15013569
DYSMA HEALTH CARE LIMITED
Registered number: 15013569
Director's Report
The director presents her report and accounts for the period ended 31 July 2024.
Principal activities
The company's principal activity during the year continued to be residential care activities for learning difficulties, mental health and substance abuse.
Directors
The following persons served as directors during the period:
Gladys Musu Prescod
Small company provisions
This report has been prepared in accordance with the provisions in Part 15 of the Companies Act 2006 applicable to companies subject to the small companies regime.
This report was approved by the board on 6 August 2024 and signed on its behalf.
Gladys Musu Prescod
Director
DYSMA HEALTH CARE LIMITED
Accountants' Report
Accountants' report to the director of
DYSMA HEALTH CARE LIMITED
You consider that the company is exempt from an audit for the period ended 31 July 2024. You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial period and of its profit or loss for the financial period.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Hamlet Accountants Ltd
266 - 268 Bethnal Green Road
London
E2 0AG
6 August 2024
DYSMA HEALTH CARE LIMITED
Profit and Loss Account
for the period from 19 July 2023 to 31 July 2024
2024
£
Turnover 3,761
Administrative expenses (3,512)
Profit before taxation 249
Tax on profit -
Profit for the period 249
DYSMA HEALTH CARE LIMITED
Registered number: 15013569
Balance Sheet
as at 31 July 2024
Notes 2024
£
Fixed assets
Tangible assets 3 640
Current assets
Cash at bank and in hand 2,070
Creditors: amounts falling due within one year 4 (2,460)
Net current liabilities (390)
Net assets 250
Capital and reserves
Called up share capital 1
Profit and loss account 249
Shareholder's funds 250
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Gladys Musu Prescod
Director
Approved by the board on 6 August 2024
DYSMA HEALTH CARE LIMITED
Statement of Changes in Equity
for the period from 19 July 2023 to 31 July 2024
Share Share Re- Profit Total
capital premium valuation and loss
reserve account
£ £ £ £ £
At 19 July 2023 - - - - -
Profit for the period 249 249
Shares issued 1 - 1
At 31 July 2024 1 - - 249 250
DYSMA HEALTH CARE LIMITED
Notes to the Accounts
for the period from 19 July 2023 to 31 July 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Leasehold land and buildings over the lease term
Plant and machinery 20% Reducing balance method
Fixtures, fittings, tools and equipment over 5 years
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Employees 2024
Number
Average number of persons employed by the company 0
3 Tangible fixed assets
Plant and machinery etc
£
Cost
Additions 800
At 31 July 2024 800
Depreciation
Charge for the period 160
At 31 July 2024 160
Net book value
At 31 July 2024 640
4 Creditors: amounts falling due within one year 2024
£
Other creditors 2,460
5 Controlling party
The company is under the control of its own director and shareholder, Gladys Musu Prescod.
6 Other information
DYSMA HEALTH CARE LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
Flat 109 Bentworth Court
80 Granby Street
London
E2 6DN
DYSMA HEALTH CARE LIMITED 15013569 false 2023-07-19 2024-07-31 2024-07-31 VT Final Accounts April 2022 15013569 2023-07-19 2024-07-31 15013569 bus:PrivateLimitedCompanyLtd 2023-07-19 2024-07-31 15013569 bus:AuditExemptWithAccountantsReport 2023-07-19 2024-07-31 15013569 bus:Director1 2023-07-19 2024-07-31 15013569 core:RetainedEarningsAccumulatedLosses 2023-07-19 2024-07-31 15013569 core:ShareCapital 2023-07-19 2024-07-31 15013569 core:SharePremium 2023-07-19 2024-07-31 15013569 2 2023-07-19 2024-07-31 15013569 countries:England 2023-07-19 2024-07-31 15013569 bus:FRS102 2023-07-19 2024-07-31 15013569 bus:FullAccounts 2023-07-19 2024-07-31 15013569 2024-07-31 15013569 core:WithinOneYear 2024-07-31 15013569 core:ShareCapital 2024-07-31 15013569 core:RetainedEarningsAccumulatedLosses 2024-07-31 15013569 core:SharePremium 2024-07-31 15013569 core:OtherReservesSubtotal 2024-07-31 15013569 2023-07-18 15013569 core:ShareCapital 2023-07-18 15013569 core:SharePremium 2023-07-18 15013569 core:OtherReservesSubtotal 2023-07-18 15013569 core:RetainedEarningsAccumulatedLosses 2023-07-18 iso4217:GBP xbrli:pure